Amy McLennan
Family · Memphis, TNNPI 1699246397
Payments from drug & device makers
Across 86 payments — averaging $13.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$288
- Lilly USA, LLC$168
- AbbVie$134
- GSK$114
- Boehringer Ingelheim$89
- Bayer$59
- plus $321 from 13 others
What the payments were for
- Food & beverage$1,174100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $288 |
| Lilly USA, LLC | 14 | $168 |
| AbbVie | 8 | $134 |
| GSK | 8 | $114 |
| Boehringer Ingelheim | 5 | $89 |
| Bayer | 3 | $59 |
| AstraZeneca | 4 | $59 |
| Abbott | 2 | $42 |
| Boston Scientific | 2 | $38 |
| Pfizer | 3 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $28 |
| Scynexis, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $11 |
How this compares
$1,174 in reported general payments places this provider in the 65th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $22,440 |
| OzempicSemaglutide | 12 | $15,419 |
| Spiriva RespimatTiotropium Bromide | 13 | $6,566 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 54 | $3,138 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $2,232 |
| Rosuvastatin Calcium | 47 | $1,070 |
| Atorvastatin Calcium | 133 | $945 |
| Potassium Chloride | 27 | $625 |
| Gabapentin | 41 | $558 |
| Amlodipine Besylate | 118 | $382 |
| Losartan Potassium | 47 | $369 |
| Sildenafil Citrate | 11 | $360 |
| Omeprazole | 38 | $356 |
| Hydralazine Hcl | 15 | $354 |
| Fluticasone Propionate | 32 | $353 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $38 | $22,44017 claims |
| Novo NordiskOzempic | $288 | $15,41912 claims |
| Boehringer IngelheimSpiriva Respimat | $89 | $6,56613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,706 family providers in Tennessee.
Other family in Memphis
- Marye BernardMemphis$128K
- Brett SnodgrassMemphis$47K
- John ScallionsMemphis$30K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.